Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. - Test2 - elhamkhani - TriplyDB

Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.

Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.

http://www.wikidata.org/entity/Q34468271

about

Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Epigenetic modulators, modifiers and mediators in cancer aetiology and progression Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer Enabling functional genomics with genome engineering Architectural and Functional Commonalities between Enhancers and Promoters Super-enhancers: Asset management in immune cell genomes Brachyury, Foxa2 and the cis-Regulatory Origins of the Notochord Cross-species oncogenomics using zebrafish models of cancer dbSUPER: a database of super-enhancers in mouse and human genome Enhancers and chromatin structures: regulatory hubs in gene expression and diseases.NaviSE: superenhancer navigator integrating epigenomics signal algebra.Enhancers as non-coding RNA transcription units: recent insights and future perspectives.CDK7-dependent transcriptional addiction in triple-negative breast cancer.SEA: a super-enhancer archive.Transcriptional Enhancers: Bridging the Genome and Phenome.Stimulus-specific combinatorial functionality of neuronal c-fos enhancers Models of human core transcriptional regulatory circuitries.Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA.The ETS family of oncogenic transcription factors in solid tumours.Krüppel Expression Levels Are Maintained through Compensatory Evolution of Shadow Enhancers.Cell type-selective disease-association of genes under high regulatory load.Tissue-specific tumorigenesis: context matters.Functional interrogation of non-coding DNA through CRISPR genome editing.Super Enhancers in Cancers, Complex Disease, and Developmental Disorders.The Yin and Yang of Chromatin Dynamics In Stem Cell Fate Selection Bivalent Regions of Cytosine Methylation and H3K27 Acetylation Suggest an Active Role for DNA Methylation at Enhancers.INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Hierarchy within the mammary STAT5-driven Wap super-enhancer.AID hits the jackpot when missing the target.7SK-BAF axis controls pervasive transcription at enhancers.NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.DNA Hypomethylation in Intragenic and Intergenic Enhancer Chromatin of Muscle-Specific Genes Usually Correlates with their Expression.Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.Small genomic insertions form enhancers that misregulate oncogenes BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells.

P2860

Q26739748-2A6461B3-5889-4C0F-8AD4-034AE3E1532D Q26766149-C5769FFD-3998-4F8C-8A12-3E8E9F4327F1 Q26771497-5534ED50-73BE-4DF7-9DE3-22AD54340DA0 Q26775423-E1F41A6F-B556-4DCF-A3E8-DF5934168ADE Q26782747-641732E5-941E-43F7-80FA-71E49B000B39 Q26796369-26383808-2546-423E-972E-5F1640603B6E Q26861020-EE84A9F9-1282-4C81-B42B-3950943FC6EC Q27309611-0A3D7FE0-9341-47CF-8840-8A04E66E6810 Q28087440-17FE611E-2F6F-42DD-BF5A-353158836A78 Q28603137-17B5A20E-12FF-414E-9F31-AC815B4E5947 Q33613467-0A9A058C-CEB2-499B-95AF-C06DC12342B0 Q33771509-EE228AB9-A52A-430B-B94D-8AFD47E79FA2 Q34046402-3C5366F4-9708-4318-B16C-FA4F1B4E9622 Q34495729-3DB9D2E8-D938-4C7A-A064-F70B494D32DF Q34502036-B486D2E1-B98C-4962-8E12-361EFE5DAEE0 Q34502174-A621EA51-4DC1-48F3-8C15-F93B652F1293 Q34502652-A26A18F3-E0FD-4414-9E4B-A1A716520E8A Q34512262-BF538642-E78E-44DB-9FD4-F00BEDCF3F82 Q34534376-5FD57B8D-8647-41C0-A8A4-2327DC213F59 Q34555986-6DC156F6-FCCE-453D-9BF1-9526F711C969 Q36090399-C67788B9-EDF2-4EBA-AF3D-BF065CCFB58B Q36160675-B7BBB4F2-6E0D-4B04-BA3D-8C119C08553B Q36296335-081C2A2C-7C3B-400B-9160-7D480896BA8F Q36306820-60E9EB77-008D-42DE-8DD2-E81FF51C8AC1 Q36401138-F2CE9152-7872-4964-93DF-84924FF9CA21 Q36522743-2BAD8497-3AFE-4F4F-B508-DCFF632665C8 Q36879662-67C2768B-D2A4-446A-9165-80EAA39EAF3F Q37051757-85BCBB8E-C5A8-497D-9C6F-073F40FAE6A3 Q37129119-7D2E024F-5468-4DC1-A916-6E3547355547 Q37131577-9E00B387-434F-4AA5-9540-277D20F05D4C Q37164471-AAB619E2-4EB8-42E9-A4B3-B8F3AA714F0C Q37170897-9CE2B8DC-641B-4458-9013-0CECB93A367E Q37240015-126095D5-712A-4E77-B432-971C9C491813 Q37269236-C961D6E7-7DFA-4FAA-9242-E9C6D56C8EFB Q37343021-05DB9F91-2D0B-4E53-B1E0-CF130B303D4C Q37517522-D84F3081-EFEE-4743-ACFD-57BF899E2DB9 Q37530126-8862A722-F609-4ED6-81E2-0B34EDD68028 Q37642474-E18FD893-65F2-487B-9531-1CE6F20DF631 Q37642694-77348D2B-C0D4-405B-8E49-873BD6779346 Q37693266-94A7D761-93D0-43AB-8197-2864351B42AA

P2860

Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.

http://www.wikidata.org/entity/Q34468271

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Convergence of developmental a ...... anscriptional super-enhancers.

@ast

Convergence of developmental a ...... anscriptional super-enhancers.

@en

Convergence of developmental a ...... anscriptional super-enhancers.

@nl

type

label

Convergence of developmental a ...... anscriptional super-enhancers.

@ast

Convergence of developmental a ...... anscriptional super-enhancers.

@en

Convergence of developmental a ...... anscriptional super-enhancers.

@nl

prefLabel

Convergence of developmental a ...... anscriptional super-enhancers.

@ast

Convergence of developmental a ...... anscriptional super-enhancers.

@en

Convergence of developmental a ...... anscriptional super-enhancers.

@nl

P1433

Q34468271-A3FBE899-A8F4-4033-B605-67F1AE42D12D

P1476

Q34468271-643B99FB-0CC3-4AAB-8ADB-F78C366BF0CE

P2093

Q34468271-0786C3CA-D3F4-4FEC-A41B-56BC102BA03A

Q34468271-2BB72B04-10EC-4458-895E-0966D46E5092

Q34468271-91FD7A3C-C315-4B5D-99F6-00C4667D1195

Q34468271-A0A31604-F578-4B74-99AB-DC7D07D1D2CD

Q34468271-DE462A4B-4219-4567-8467-7465CA4290A2

P2860

Q34468271-013973E3-8845-4731-8350-CC24BC48F768

Q34468271-0483F1BD-08F9-4BA2-AFC8-3715DBBC7536

Q34468271-06C78DE9-FF16-4320-8246-A61E38A55B8B

Q34468271-0A62F46C-1F66-437D-8EC6-2E54773E4CE6

Q34468271-133D31E5-14D6-466A-8AE7-097CFEFDB4FE

Q34468271-1D98928C-64C7-44AD-B720-D0061BA68FF1

Q34468271-39719586-4333-47CA-BFBE-384F6FB88C5F

Q34468271-3CA421EB-5168-4989-9324-07986DF13840

Q34468271-4541392B-B42D-456A-9F19-AD1EA28FED1C

Q34468271-47130F06-043B-4AF8-80EE-5EB30F55783E

P304

Q34468271-61F7BB25-9525-48BF-8E78-4474E9E003E5

P31

Q34468271-8E43B584-0204-4096-A7EF-E24EA4E256BB

P356

Q34468271-1780DAAA-B56E-4987-9C52-7BCBAFEC0FB3

P433

Q34468271-8B5D8725-68CE-458C-A1A5-0ABC2F311DA1

P478

Q34468271-3B3B58B3-B6AD-4C76-837C-FB00EFDA1F74

P50

Q34468271-00616BCD-8517-4D37-B94A-2FA8CAF5BCB8

Q34468271-9DEEC6BD-ADC1-4C2F-A9BB-B54E30891343

Q34468271-CB1E1129-9F9A-4A11-8630-7588242A4E43

P577

Q34468271-F4EE3CF5-1D11-4CBA-B986-D30525CEE036

P5875

Q34468271-DD415B1C-86A1-4B97-923C-ACA4DD7ED0D2

P698

Q34468271-19A6DD7E-C91D-4C1F-94DB-A11BDB173825

P932

Q34468271-22CE27D7-FE25-462D-B29F-3E178E29FEDA

P356

J.MOLCEL.2015.02.014

P1433

P1476

Convergence of developmental a ...... anscriptional super-enhancers.

@en

P2093

Abraham S Weintraub

http://www.w3.org/2001/XMLSchema#string

Charles Y Lin

http://www.w3.org/2001/XMLSchema#string

James E Bradner

http://www.w3.org/2001/XMLSchema#string

Jurian Schuijers

http://www.w3.org/2001/XMLSchema#string

Tong Ihn Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4

An integrated encyclopedia of DNA elements in the human genome

Hallmarks of Cancer: The Next Generation

Identification of c-MYC as a target of the APC pathway

Locus control regions

Wnt/β-catenin signaling and disease

Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes

Lack of sik1 in mouse embryonic stem cells impairs cardiomyogenesis by down-regulating the cyclin-dependent kinase inhibitor p57kip2

Genetic and epigenetic fine mapping of causal autoimmune disease variants

Super-enhancers in the control of cell identity and disease

P304

362-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLCEL.2015.02.014

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Brian J. Abraham

P577

2015-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274086398

http://www.w3.org/2001/XMLSchema#string

P698

25801169

http://www.w3.org/2001/XMLSchema#string

P932

4402134

http://www.w3.org/2001/XMLSchema#string